Refine by
Cancer Detection Articles & Analysis
64 articles found
As Colorectal Cancer Awareness Month closes, Guardant Health reflects on the journey to develop a blood-based test for colorectal cancer screening. Over the last decade, the effort culminated in an approach that is now FDA-approved, guideline-recommended, and reimbursable, enabling the launch of Shield to support earlier detection and improved ...
ICA is one of the most successful and widely used point-of-care tests (POCT) and has been successfully used for human chorionic gonadotropin (hCG) detection, serodiagnostic assays, cancer detection, cardiac markers and infectious microorganism detection. ...
As a result, lipidomic profiling of exosomes holds potential as a diagnostic tool for detecting cancer and monitoring treatment response. Moreover, lipidomic shifts can also reveal insights into metabolic conditions such as obesity, diabetes, and neurodegenerative diseases. ...
Traditional approaches often fall short in detecting cancers early or accurately characterizing subtypes necessary for effective treatment. ...
The emergence of chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of certain cancers, providing a promising targeted approach to eliminate cancer cells. ...
·Intracellular Sensors and Biosensors Developing intracellular sensors and biosensors has enabled real-time monitoring of the cytoskeletal dynamics. These sensors can detect changes in protein interactions, mechanical forces, or cellular states. Applications: Cell Biology: Understanding mechanical signal transduction and cytoskeletal responses to environmental changes. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
In the past few years, Raman has been used in dental and cancer studies, and is now building on this success by extension into Point-of-Care (POC) applications. This article gives an overview of some very new and exciting research into the use of Raman spectroscopy for the detection of cancerous tissue, biomarkers of disease, and pathogens that ...
ByB&W Tek
CDH1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway, which is often dysregulated in cancer. What is the role of CDH1 in cancer? The loss or dysfunction of CDH1 has been implicated in the development and progression of various types of cancer. ...
In addition, the Carbon-13 Urea Breath Test is a safe and highly accurate diagnostic tool for detecting the presence of Helicobacter pylori infection in the stomach. ...
It is predicated on the judicious fabrication of Oncolytic Viruses (OVs), biological entities ingeniously engineered to detect, invade, and obliterate cancerous cells while sparing healthy cells unscathed. ...
How is nano-flow cytometry being used to improve early disease detection? Cancer detection: Nano-flow cytometry is being used by researchers to create new blood tests that can identify cancer cells in their earliest stages. As an illustration, scientists at the University of California, Los Angeles have created a brand-new blood ...
Relationship Between Immunity, Inflammation and Cancer Immunity is an act of self-protection of the body. The immune response is divided into specific and non-specific. ...
Therefore, quantum dot-labeled microspheres can be used for multiplex detection of miRNA overexpression in human lung cancer cells. Fluorescent Microspheres for Protein Detection Multi-color quantum dot-bound microspheres have been widely proven to be used for the simultaneous detection of multiple antigens, including IgG, tumor ...
WES offers a simpler, more cost-effective, and efficient alternative to whole genome sequencing, with higher target region coverage, facilitating accurate variant detection. Enhancing Cancer Genomic Research with WES Mutations occurring within the whole exome regions of the cancer genome play a pivotal role in tumor development. WES's precise ...
BioMark Diagnostics Inc. is a Canadian-based cancer diagnostic company with head office located in Richmond, British Columbia and operating lab in Quebec City, Quebec. ...
INOVIQ (IIQ) signs a contract research agreement with Nicoya Lifesciences to develop a SubB2M-based test that uses its Alto digital surface plasmon resonance (SPR) platform The company believes a SubB2M-based SPR test has the potential to be developed as a multi-cancer detection test that first detects the Neu5Gc cancer ...
Unfortunately, today’s technologies for TB detection fits none of these criteria, and so a better solution is urgently needed. ...
Yale Medicine, an academic medical center with a high volume of prostate biopsies, conducted a study to determine Paige Prostate’s utility as a prescreening tool for clinical use. A total of 1,876 prostate core biopsy slides were analyzed by Paige Prostate, and only those cores categorized by the AI as “suspicious” or as out of distribution were manually reviewed by Yale ...